Work

Complete Pathologic Response to Pembrolizumab and Axitinib in a Patient With Sarcomatoid RCC and Ocrelizumab-Treated Multiple Sclerosis

Year: 2021

Type: article

Study design: Case Report

Source: Urology

DOI: 10.1016/j.urology.2021.12.015

Authors: Kevin Neuzil, Kathryn Gessner, John Hedgepeth, Sara E. Wobker, Eric M. Wallen, Katherine P. Morgan, Marc A. Bjurlin, Tracy L. Rose

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute

Awards: G6434586985, UNC Integrated Translational Oncology Program (UNC-iTOP)

OpenAlex ID: W4200327294

FWCI: 0.649

Cites: 16

Cited by: 4

Related to: 10